SB225 Alabama 2017 Session
Summary
- Primary Sponsor
William “Bill” M. BeasleySenatorDemocrat- Session
- Regular Session 2017
- Title
- Pharmacy, State Board of, inspectors renamed investigators, maximum fees increased, frequency of drug supply chain registration increased, further regulation of entities within drug supply chain provided, resale of compound drug products prohibited, Sec. 34-23-32.2 added; Secs. 34-23-152 to 34-23-157, inclusive, repealed; Secs. 20-2-9, 20-2-190, 34-23-1, 34-23-3, 34-23-9, 34-23-30, 34-23-32, 34-23-32.1, 34-23-33, 34-23-70, 34-23-92, 34-23-131, 34-23-159, 34-23-160, 34-23-162 am'd
- Summary
SB225 updates Alabama's Pharmacy laws by renaming inspectors to investigators, expanding drug-supply-chain regulation, and tightening rules on compounding and permit requirements.
What This Bill DoesRenames the board's drug inspectors as drug investigators and affirms pharmacists as health care providers. Expands the scope and frequency of drug-supply-chain registration, adds more types of supply-chain entities, and raises certain permit fees. Requires permits for shipping legend drugs into Alabama, gives the board power to request trading-partner lists, and imposes penalties for violations or fraudulent registrations. Aligns compounding rules with USP/NF standards, strengthens pharmacy technician registration and continuing education, and adopts FDA Drug Quality and Security Act guidelines; repeals older compounding laws.
Who It Affects- Pharmacists, pharmacies, and pharmacy technicians in Alabama will face updated registration, education requirements, display requirements, and potential disciplinary actions for noncompliance or fraudulent registration.
- Manufacturers, bottlers, packagers, repackagers, third-party logistics providers, private label distributors, wholesale drug distributors, and other pharmacy-related businesses in the drug supply chain will face annual registration, new permit requirements, higher fees, and obligations to comply with FDA guidelines and maintain trading-partner records.
Key ProvisionsAI-generated summary using openai/gpt-5-nano on Feb 24, 2026. May contain errors — refer to the official bill text for accuracy.- Rename state Board of Pharmacy drug inspectors to drug investigators.
- Affirm pharmacist as a health care provider and define pharmacist for regulatory purposes.
- Specify qualifications laboratories must meet for the board to use their product analysis data.
- Increase maximum fees for new pharmacy permits, permit renewals, and permit transfers; set fee ranges for out-of-state permit applications and renewals.
- Increase drug supply chain registration frequency from biennial to annual; add packagers, third-party logistic providers, private label distributors, and other supply-chain entities to registration requirements; adjust transfer-of-ownership permit fees.
- Prohibit any supply-chain entity from shipping a legend drug or device into the state without a valid board permit; impose civil penalties for violations.
- Require permit holders to provide a list of all trading partners upon request by the board.
- Authorize the board to discipline pharmacists who obtain registration through fraudulent means.
- Strengthen initial and renewal registration and continuing education requirements for pharmacy technicians.
- Prohibit a prescriber from reselling a compounded drug product administered in their office; require enforcement of USP/National Formulary drug handling and compounding standards.
- Authorize the board to permit manufacturers, affiliates, bottlers, packagers, repackagers, third-party logistics providers, wholesale distributors, private label distributors, or other supply-chain entities to ship drugs in compliance with FDA guidelines under the Drug Quality and Security Act.
- Add Section 34-23-32.2 to require adherence to FDA guidelines; allow the board to set fees and fines; use proceeds to fund permitting, inspecting, and investigating supply-chain entities.
- Repeal Sections 34-23-152 to 34-23-157 related to compounding of drugs.
- Subjects
- Pharmacy, Alabama State Board of
Bill Actions
Pending third reading on day 20 Favorable from Health
Read for the second time and placed on the calendar
Read for the first time and referred to the House of Representatives committee on Health
Engrossed
Motion to Read a Third Time and Pass adopted Roll Call 558
Beasley motion to Adopt adopted Roll Call 557
Health and Human Services first Substitute Offered
Third Reading Passed
Read for the second time and placed on the calendar with 1 substitute and
Read for the first time and referred to the Senate committee on Health and Human Services
Bill Text
Votes
Beasley motion to Adopt
Documents
Source: Alabama Legislature